Medicine
Health Equity in Clinical Trial Recruitment Strategies
Quick fact
In the U.S., African Americans make up about 13% of the population but only about 5% of clinical trial participants, and some drugs have been found to work differently (or cause different side effects) across racial groups—a direct result of non-representative trial populations.
Why this is interesting
You'd think a clinical trial would want the most representative group of patients possible—yet most trials still enroll mainly White, urban, and educated participants. Why does this gap persist, and who decides who gets a chance to be in the study?